Ambassador and Directors Emeritus
- What we do
- Ambassador and Directors Emeritus
- Our Ambassadors Emeritus
- Our Directors Emeritus
- Function

Ambassador and Directors Emeritus
AMBASSADOR AND DIRECTORS EMERITUS
Outstanding individuals
These honorary titles are awarded in recognition of the exemplary work, commitment, and outstanding philanthropic involvement of individuals who have wholeheartedly supported PROCURE’s mission.
Jean Pagé – Ambassador Emeritus of PROCURE
For over 15 years, Jean Pagé has been able to carry PROCURE’s mission at arm’s length. Diagnosed himself with prostate cancer at the age of 49, he transformed his fight into a united action to help all men and families burdened by this disease, by raising their awareness of the importance of screening and prevention.
A committed man, he has broken taboos around prostate cancer for years and has given many men the chance to break out of isolation and speak out about their disease. Associated as ambassador and spokesperson for PROCURE, he was able to promote this cause, which affects 12 Quebecers every day.
On January 29, 2019, PROCURE’s Board of Directors awarded Jean Pagé, in recognition of the exemplary work he has done, and his commitment over the last 15 years, the most prestigious honorary title of PROCURE, the Ambassador Emeritus of PROCURE.
Even at the end of his life, Jean was there to support the cause. Even if he could not be physically present, he remotely followed the 13th edition of the Jean-Pagé Walk of Courage, thanks to his family and through the media and social networks. He showed an unwavering commitment that touched us all.
On December 9, 2019, it was with a heavy heart that his spouse Brigitte Bélanger and all children, Isabelle, Alexandra, Élisabeth, and William, announced the death of our dear Ambassador Emeritus. He died peacefully surrounded by his family in his house.
We cannot thank him enough for all that he has brought to PROCURE and to his battle in the fight against prostate cancer. His philanthropic involvement was out of the ordinary and we could not have done it without him. Today, his daughter Isabelle takes up the cause and together we will continue his fight and will honor his memory in each of our actions, because «There is something about Jean in me, which is in us all and which will stay forever» Cédric Bisson, Chairman of the PROCURE Board of Directors.
Supporters of PROCURE on all fronts
Other pages that might interest you
Additional Information - Prostate cancer

Is prostate cancer hereditary?
Understanding the hereditary and genetic aspects of this disease can provide valuable information to both individuals affected and their families.

Symptoms, risk and screening
Are you over 50 or experiencing urinary problems? Discover why early screening for prostate diseases is important.

Genetics and prostate cancer
Do you have a family history of cancer? Your doctor might recommend genetic screening.

Genetic predisposition to prostate cancer
Although rare, some hereditary genetic mutations can increase your risk of prostate cancer.

From prostate to screening
Learn about the role of your prostate, related diseases, symptoms to watch out for and risk factors.

Vitamin D deficiency may be linked to aggressive prostate cancer
The Benefits of Vitamin D A great amount of research present the multiple benefits of Vitamin D. For example, Vitamin D regulates the amount of calcium and phosphorus, helps build bones and brings many more benefits to other tissues in the body, including kidneys, intestines and parathyroid glands. In fact, past reasearch found a link […]

Are you at risk? What causes prostate cancer?
The exact causes of prostate cancer are not yet well understood. Researchers have found some risk factors and are trying to determine how these factors lead to prostate cancer.

Fat may fuel prostate cancer growth
Being overweight or obese may increase a man’s risk of aggressive prostate cancer, researchers believe after doing animal and human cell studies.
Sources and references
Last medical and editorial review: April 2024. See our web page validation committee and our collaborators by clicking here.